Moderate‐to‐severe Atopic Dermatitis in Adolescents Treated with Dupilumab: A Multicentre Italian Real‐world Experience
JEADV Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology（2022）
摘要
Moderate‐to‐severe atopic dermatitis (AD) in the adolescence is a high burden disease, and its treatment can be very challenging due to paucity of approved systemic drugs for this age and their side‐effects. Dupilumab was recently approved for treatment of adolescent AD.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要